# Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque

> **NCT02316886** · PHASE4 · COMPLETED · sponsor: **Seung-Jung Park** · enrollment: 1608 (actual)

## Conditions studied

- Coronary Artery Disease
- Plaque, Atherosclerotic

## Interventions

- **DEVICE:** Coronary intervention
- **DRUG:** Optimal Medical treatment

## Key facts

- **NCT ID:** NCT02316886
- **Lead sponsor:** Seung-Jung Park
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-05
- **Primary completion:** 2023-10-19
- **Final completion:** 2023-10-19
- **Target enrollment:** 1608 (ACTUAL)
- **Last updated:** 2023-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02316886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02316886, "Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02316886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*